Heart rate variability and metabolic syndrome in hospitalized patients with schizophrenia

Journal of Korean Academy of Nursing

Volumn 41, Issue 6, 2011, Pages 788-794

  Lee, Kyunghee ^a   Park, Jeongeon ^b   Choi, Jeongim ^c   Park, Chang Gi ^d  

^a Keimyung University   (South Korea)

^b Gyeongsan University College   (South Korea)

^c Dongsan Medical Center   (South Korea)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Metabolic syndrome X; Schizophrenia

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HOSPITALIZATION; HUMAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MORTALITY; OBESITY; PATHOPHYSIOLOGY; SCHIZOPHRENIA;

ADULT; AUTONOMIC NERVOUS SYSTEM; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; FEMALE; HEART RATE; HOSPITALIZATION; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; SCHIZOPHRENIA; TRIGLYCERIDES;

EID: 84922685409     PISSN: 20053673     EISSN: 20937482     Source Type: Journal    
DOI: 10.4040/jkan.2011.41.6.788     Document Type: Article

References (30)

1. Agelink, M. W., Majewski, T., Wurthmann, C., Lukas, K., Ullrich, H., Linka, T., et al. (2001). Effects of newer atypical antipsychotics on autonomic neurocardiac function: A comparison between amisulpride, olanzapine, sertindole, and clozapine. Journal of Clinical Psychopharmacology, 21, 8-13.
2. Astrup, A. S., Tarnow, L., Rossing, P., Hansen, B. V., Hilsted, J., & Parving, H. H. (2006). Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Diabetes Care, 29, 334-339. doi: 10.2337/diacare.29.02.06.dc05-1242
3. Bar, K. J., Letzsch, A., Jochum, T., Wagner, G., Greiner, W., & Sauer, H. (2005). Loss of efferent vagal activity in acute schizophrenia. Journal of Psychiatric Research, 39, 519-527.
4. Birkhofer, A., Alger, P., Schmid, G., & Forstl, H. (2007). The cardiovascular risk of schizophrenic patients. Neuropsychiatry, 21, 261-266.
5. Boettger, S., Hoyer, D., Falkenhahn, K., Kaatz, M., Yeragani, V. K., & Bar, K. J. (2006). Altered diurnal autonomic variation and reduced vagal information flow in acute schizophrenia. Clinical Neurophysiology, 117, 2715-2722. doi: 10.1016/j.clinph.2006.08.009
6. Cohen, H., Loewenthal, U., Matar, M., & Kotler, M. (2001). Association of autonomic dysfunction and clozapine. Heart rate variability and risk for sudden death in patients with schizophrenia on long-term psychotropic medication. The British Journal of Psychiatry, 179, 167-171.
7. Grundy, S. M., Cleeman, J. I., Merz, C. N., Brewer, H. B. Jr., Clark, L. T., Hunninghake, D. B., et al. (2004). Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation, 110, 227-239.
8. Henry, B. L., Minassian, A., Paulus, M. P., Geyer, M. A., & Perry, W. (2010). Heart rate variability in bipolar mania and schizophrenia. Journal of Psychiatric Research, 44, 168-176. doi: 10.1016/j.jpsychires.2009.07.011
9. Ikawa, M., Tabuse, H., Ueno, S., Urano, T., Sekiya, M., & Murakami, T. (2001). Effects of combination psychotropic drug treatment on heart rate variability in psychiatric patients. Psychiatry and Clinical Neurosciences, 55, 341-345. doi: 10.1046/j.1440-1819.2001.00873.x
10. Karason, K., Molgaard, H., Wikstrand, J., & Sjostrom, L. (1999). Heart rate variability in obesity and the effect of weight loss. American Journal of Cardiology, 83, 1242-1247. doi: 10.1016/S0002-9149(99)00066-1
11. Kelly, D. L., McMahon, R. P., Liu, F., Love, R. C., Wehring, H. J., Shim, J. C., et al. (2010). Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: A retrospective cohort study. Journal of Clinical Psychiatry, 71, 304-311. doi: 10.4088/JCP.08m04718yel
12. Kim, J. A., Park, Y. G., Cho, K. H., Hong, M. H., Han, H. C., Choi, Y. S., et al. (2005). Heart rate variability and obesity indices: Emphasis on the response to noise and standing. Journal of the American Board of Family Practice, 18, 97-103. doi: 10.1152/japplphysiol.01275.2005
13. Kuch, B., Hense, H. W., Sinnreich, R., Kark, J. D., von Eckardstein, A., Sapoznikov, D., et al. (2001). Determinants of short-period heart rate variability in the general population. Cardiology, 95, 131-138.
14. Kudat, H., Akkaya, V., Sozen, A. B., Salman, S., Demirel, S., Ozcan, M., et al. (2006). Heart rate variability in diabetes patients. Journal of International Medical Research, 34, 291-296.
15. La Rovere, M. T., Bigger, J. T. Jr., Marcus, F. I., Mortara, A., & Schwartz, P. J. (1998). Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet, 351, 478-484. doi: 10.1016/S0140-6736(97)11144-8
16. La Rovere, M. T., Pinna, G. D., Hohnloser, S. H., Marcus, F. I., Mortara, A., Nohara, R., et al. (2001). Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: Implications for clinical trials. Circulation, 103, 2072-2077.
17. Lee, W. Y., Park, J. S., Noh, S. Y., Rhee, E. J., Kim, S. W., & Zimmet, P. Z. (2004). Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects. Diabetes Research and Clinical Practice, 65, 143-149.
18. Liao, D., Carnethon, M., Evans, G. W., Cascio, W. E., & Heiss, G. (2002). Lower heart rate variability is associated with the development of coronary heart disease in individuals with diabetes: The atherosclerosis risk in communities (ARIC) study. Diabetes, 51, 3524-3531.
19. Mann, K., Rossbach, W., Muller, M. J., Muller-Siecheneder, F., Ru, H., & Dittmann, R. W. (2004). Heart rate variability during sleep in patients with schizophrenia treated with olanzapine. International Clinical Psychopharmacology, 19, 325-330.
20. McEvoy, J. P., Meyer, J. M., Goff, D. C., Nasrallah, H. A., Davis, S. M., Sullivan, L., et al. (2005). Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophrenia Research, 80, 19-32. doi: 10.1016/j.schres.2005.07.014
21. Meyer, J. M. (2001). Effects of atypical antipsychotics on weight and serum lipid levels. Journal of Clinical Psychiatry, 62, 27-34.
22. Meyer, J. M., Nasrallah, H. A., McEvoy, J. P., Goff, D. C., Davis, S. M., Chakos, M., et al. (2005). The Clinical Antipsychotic trials Of Intervention Effectiveness (CATIE) Schizophrenia trial: Clinical comparison of subgroups with and without the metabolic syndrome. Schizophrenia Research, 80, 9-18. doi: 10.1016/j.schres.2005.07.015
23. Montano, N., Gneddhi, R.T., Porta, A., Lombardi, F., Pagani, M., & Malliani, A. (1994). Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. Circulation, 90, 1826-1831.
24. Oh, J. Y., Hong, Y. S., Sung, Y. A., & Barrett-Connor, E. (2004). Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Diabetes Care, 27, 2027-2032. doi: 10.2337/diacare.27.8.2027
25. Sugawara, N., Yasui-Furukori, N., Sato, Y., Kishida, I., Yamashita, H., Saito, M., et al. (2011). Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia. Annals of General Psychiatry, 10(21), 1-8. doi: 10.1186/1744-859X-10-21
26. Suvisaari, J. M., Saarni, S. I., Perala, J., Suvisaari, J. V., Harkanen, T., Lonnqvist, et al. (2007). Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey. Journal of Clinical Psychiatry, 68, 1045-1055.
27. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. (1996). Heart rate variability: Standards of measurement, physiological interpretation, and clinical use. Circulation, 93, 1129-1136.
28. Van Ravenswaaij-Arts, C. M., Kollee, L. A., Hopman, J. C., Stoelinga, G. B., & van Geijn, H. P. (1993). Heart rate variability. Annals of Internal Medicine, 118, 436-447.
29. WHO, IASO, & IOTF. (2000). The Asia-Pacific perspective: Redefining obesity and its treatment. Australia: Health Communications, 1-56.
30. Wang, Y. C., Yang, C. C., Bai, Y. M., & Kuo, T. B. (2008). Heart rate variability in schizophrenic patients switched from typical antipsychotic agents to amisulpride and olanzapine: 3-month follow-up. Neuropsychobiology, 57, 200-205. doi: 10.1159/000149818